Rucaparib: a new treatment option for ovarian cancer

Sabatucci, I; Maltese, G; Lepori, S; Tripodi, E; Bogani, G; Lorusso, D

Lorusso, D (reprint author), Fdn IRCCS Ist Nazl Tumori, Dept Gynecol Oncol, Milan, Italy.

EXPERT OPINION ON PHARMACOTHERAPY, 2018; 19 (7): 765

Abstract

Introduction: Approximately 50% of high-grade serous ovarian cancers present a deficiency in the pathways involved in homologous recombination (HR). P......

Full Text Link